ACE-Breast-02: a Randomized Phase III Trial of ARX788 Versus Lapatinib Plus Capecitabine for HER2-positive Advanced Breast Cancer
Signal transduction and targeted therapy(2025)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
Signal transduction and targeted therapy(2025)